UNITED ~~STATESSECURITIES~~STATES ~~AND EXCHANGE COMMISSIONWashington, D.C. 20549~~

~~Form~~SECURITIES ~~6-K~~AND EXCHANGE COMMISSION

~~REPORT~~Washington, OFD.C. ~~FOREIGN~~20549 ~~PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934~~

~~Date~~FORM of6-K ~~Report: June 11, 2026~~

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

Date of Report: June 25, 2026

Commission File Number: 001-36891

Cellectis S.A.~~(Translation~~ ~~of registrant's name into English)~~

8,(Exact ~~rue~~Name deof laregistrant ~~Croix~~as ~~Jarry~~specified ~~75013~~in ~~Paris,~~its ~~France +33 1 81 69 16 00 (Address of principal executive office~~charter)

~~Indicate~~8, byrue ~~check~~de ~~mark~~la ~~whether~~Croix ~~the~~Jarry ~~registrant files or will file annual reports under cover of Form 20-F or Form 40-F.Form 20-F [ X ] Form 40-F [ ]~~

~~EXHIBIT~~75013 ~~INDEX~~Paris, France

Exhibit		Title
99.1		Press Release dated June 11, 2026

+33 1 81 69 16 00

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  Form 40-F 

Cellectis S.A.

The information included in this report on Form 6-K, including Exhibit 99.1, shall be deemed to be incorporated by reference in the registration statements of Cellectis S.A. on Form F-3 (Nos. 333-284302 and 333-288491) and Form S-8 (Nos. 333-204205, 333-214884, 333-222482, 333-227717, 333-258514, 333-267760, 333-273777, 333-284301 and 333-290218), to the extent not superseded by documents or reports subsequently filed.

Combined Shareholders Meeting Voting Results

Cellectis S.A. (the “Company”) held its Combined General Meeting of Shareholders on June 25, 2026. The voting results of the Meeting, attached as Exhibit 99.1 hereto, are incorporated by reference herein.

EXHIBITS


Exhibit		Title
99.1		Voting Results for the Combined General Meeting of Shareholders

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Cellectis S.A.
		CELLECTIS S.A.
	(Registrant)
June 25, 2026		By:	/s/ André Choulika
Date: June 11, 2026	/s/ André Choulika
			André Choulika
	André Choulika
			Chief Executive Officer
	Chief Executive Officer

Filing Compare · Cellectis S.A.